Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Think Surgical's TMINI Surgical Robot OK'ed for LinkSymphoKnee

What are you searching for?

Sign in
OEM News

Think Surgical’s TMINI Surgical Robot OK’ed for LinkSymphoKnee

The Link SymphoKnee was added to Think Surgical’s ID-HUB, a proprietary databank of implant modules.

Author Image

By: Sam Brusco

Associate Editor

Think Surgical has earned a new U.S. Food and Drug Administration (FDA) 510(k) clearance for its TMINI miniature robotic system. The FDA nod covers use with Waldemar Link’s (LINK) LinkSymphoKnee (LSK) under a collaboration between the duo.

The Link SymphoKnee was added to Think Surgical’s ID-HUB, a proprietary databank of implant modules for use on the open platform version of TMINI in the U.S.

“At LINK, we have always prioritized innovation in orthopedic solutions, focusing on how we can empower our customers—the surgeons—with tools that can be used to elevate precision, adaptability, and patient outcomes,” said Peter Willenborg, CEO of LINK.

In September the TMINI robot was awarded FDA clearance for use with Zimmer Biomet’s Persona knee system. This made Think Surgical the only company at present with with a robotic system that has both an implant-exclusive option with the Persona knee and an open platform for implants from multiple other manufacturers for total knee replacement.

“THINK Surgical is excited to add the LinkSymphoKnee to the TMINI System. The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic, and guided motion knees on a single robotic platform.” said Stuart Simpson, president and CEO of Think Surgical.

In July, the company also earned FDA clearance for its TMINI 1.1 system software, which allows positional refinement and optimization of the implant tailored to patient needs.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Add Orthopedic Design & Technology as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters

Topics